Skip to main content

Table 3 Correlation between SNF5 expression and different clinicopathologic features in ECs

From: Expression and potential role of SNF5 in endometrial carcinoma

Characteristics Samples (n) SNF5 expression P-value
Positive Negative
Ages
  ≥ 50 40 25 15 0.318
  < 50 6 5 1  
Pathologic subtype
 Endometrioid 40 28 12 0.079
 Non-endometrioid 6 2 4  
FIGO stage
 I 31 20 11 0.761
 II 8 6 2  
 III 7 4 3  
Histological grade
 G1 18 14 4 0.152
 G2 and G3 28 16 12  
Myometrial invasion
  ≥ 1/2 15 12 3 0.626
  < 1/2 31 18 13  
Lymphatic metastasis
 Yes 7 4 3 0.143
 No 39 26 13  
ER expression
 positive 29 19 10 0.956
 negative 17 11 6  
PR expression
 positive 31 23 8 0.024*
 negative 15 6 9  
  1. FIGO 2009 International Federation of Gynecology and Obstetrics staging system
  2. *P < 0.05